603392 Stock Overview
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 603392 from our risk checks.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥73.17 |
| 52 Week High | CN¥89.89 |
| 52 Week Low | CN¥46.30 |
| Beta | 2.26 |
| 11 Month Change | -3.67% |
| 3 Month Change | 0.63% |
| 1 Year Change | 50.71% |
| 33 Year Change | -39.62% |
| 5 Year Change | n/a |
| Change since IPO | -9.29% |
Recent News & Updates
Recent updates
Shareholder Returns
| 603392 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 1.4% | -2.6% | -2.1% |
| 1Y | 50.7% | -20.9% | 2.8% |
Return vs Industry: 603392 exceeded the CN Biotechs industry which returned -20.9% over the past year.
Return vs Market: 603392 exceeded the CN Market which returned 2.8% over the past year.
Price Volatility
| 603392 volatility | |
|---|---|
| 603392 Average Weekly Movement | 5.6% |
| Biotechs Industry Average Movement | 9.0% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 603392 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603392's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 3,710 | Zhiming Jiang | www.ystwt.com |
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides chemiluminescence series, assembly line series, nucleic acid series, dry type fluorescent immunoassay, and fully automatic blood type analyzer and reagents; ELISA kits; rapid diagnosis; bole series; and supporting reagents.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Fundamentals Summary
| 603392 fundamental statistics | |
|---|---|
| Market cap | CN¥92.57b |
| Earnings (TTM) | -CN¥294.04m |
| Revenue (TTM) | CN¥2.49b |
37.2x
P/S Ratio-314.8x
P/E RatioIs 603392 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603392 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.49b |
| Cost of Revenue | CN¥959.58m |
| Gross Profit | CN¥1.53b |
| Other Expenses | CN¥1.82b |
| Earnings | -CN¥294.04m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.23 |
| Gross Margin | 61.46% |
| Net Profit Margin | -11.81% |
| Debt/Equity Ratio | 2.1% |
How did 603392 perform over the long term?
See historical performance and comparison